New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 19, 2012
13:24 EDTMCK, GSK, CAH, ABCGlaxoSmithKline settles nasal spray litigation for $150M, Reuters reports
GlaxoSmithKline Plc (GSK) has reached a preliminary $150M settlement with U.S. drug wholesalers regarding generic nasal spray litigation, according to Reuters. Reference Link
News For GSK;ABC;CAH;MCK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 27, 2015
06:19 EDTGSKPharmceutical companies buy drugs and raises prices, WSJ reports
Subscribe for More Information
April 24, 2015
07:11 EDTGSKAgenus: GSK's RTS,S vaccine showed statistically significant results in study
Subscribe for More Information
April 23, 2015
13:16 EDTMCK, ABC, CAHPharmacies, PBMs seen as potential buyers after Omnicare said to explore sale
Subscribe for More Information
April 20, 2015
11:32 EDTCAHCardinal Health to pay $26.8M to settle FTC charges
In its latest action to ensure competition in the nationís healthcare markets, the FTC announced that Cardinal Health has agreed to resolve charges that it illegally monopolized 25 local markets for the sale and distribution of low-energy radiopharmaceuticals and forced hospitals and clinics to pay inflated prices for these drugs. The proposed stipulated order requires Cardinal to pay $26.8M of ill-gotten gains and represents the second largest monetary settlement the FTC has obtained in an antitrust case. The money will be deposited into a fund for distribution to injured customers. The order also includes provisions to prevent future violations and restore competition in six markets where Cardinal remains the dominant radiopharmacy. Reference Link
07:20 EDTGSKAmerican Association for Cancer Research to hold annual meeting
Subscribe for More Information
07:01 EDTGSKPernix Therapeutics obtains six months U.S. pediatric exclusivity for Treximet
Subscribe for More Information
April 16, 2015
10:04 EDTMCKHigh option volume stocks
Subscribe for More Information
09:14 EDTGSKAdamis says albuterol HFA product study met clinical FEV1 primary endpoint
Subscribe for More Information
08:15 EDTGSKGlaxoSmithKline and Theravance announce launch of Anoro in Spain
In a regulatory filing, GlaxoSmithKline (GSK) and Theravance (THRX) announced the launch of Anoro in Spain following the approval in Europe in May 2014. Anoro Ellipta is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease. Anoro Ellipta is a combination of two bronchodilators, umeclidinium, a long-acting muscarinic antagonist and vilanterol, a long-acting beta2 agonist, in a single dry powder inhaler, the Ellipta. The approved dose of UMEC/VI is 55/22mcg. UMEC/VI has been developed under the 2002 LABA collaboration agreement between Glaxo Group Limited and Theravance.
07:05 EDTCAH, MCK, ABCNovaBay signs distribution agremeent with AmerisourceBergen
Subscribe for More Information
April 15, 2015
11:53 EDTGSKGlaxoSmithKline initiated with a Sell at Societe Generale
10:36 EDTCAH, MCKBofA/Merrill U.S. credit analysts hold an analyst/industry conference call
Subscribe for More Information
April 13, 2015
14:07 EDTCAHEarnings Watch: Johnson & Johnson shares down slightly since last earnings
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use